Selective Pyramidal Cell Reduction of GABAA Receptor α1 Subunit Messenger RNA Expression in Schizophrenia
Authors:
- 15 June 2011
- journal article
- research article
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 36 (10) , 2103-2110
Abstract
Levels of messenger RNA (mRNA) for the α1 subunit of the GABAA receptor, which is present in 60% of cortical GABAA receptors, have been reported to be lower in layer 3 of the prefrontal cortex (PFC) in subjects with schizophrenia. This subunit is expressed in both pyramidal cells and interneurons, and thus lower α1 subunit levels in each cell population would have opposite effects on net cortical excitation. We used dual-label in situ hybridization to quantify GABAA α1 subunit mRNA expression in calcium/calmodulin-dependent kinase II α (CaMKIIα)-containing pyramidal cells and glutamic acid decarboxylase 65 kDa (GAD65)-containing interneurons in layer 3 of the PFC from matched schizophrenia and healthy comparison subjects. In subjects with schizophrenia, mean GABAA α1 subunit mRNA expression was significantly 40% lower in pyramidal cells, but was not altered in interneurons. Lower α1 subunit mRNA expression in pyramidal cells was not attributable to potential confounding factors, and thus appeared to reflect the disease process of schizophrenia. These results suggest that pyramidal cell inhibition is reduced in schizophrenia, whereas inhibition of GABA neurons is maintained. The cell type specificity of these findings may reflect a compensatory response to enhance layer 3 pyramidal cell activity in the face of the diminished excitatory drive associated with the lower dendritic spine density on these neurons.Keywords
This publication has 46 references indexed in Scilit:
- Gamma Oscillatory Power is Impaired During Cognitive Control Independent of Medication Status in First-Episode SchizophreniaNeuropsychopharmacology, 2010
- Alterations of Cortical GABA Neurons and Network Oscillations in SchizophreniaCurrent Psychiatry Reports, 2010
- Hippocampal theta rhythm and its coupling with gamma oscillations require fast inhibition onto parvalbumin-positive interneuronsProceedings of the National Academy of Sciences, 2009
- Reduced Cortical Cannabinoid 1 Receptor Messenger RNA and Protein Expression in SchizophreniaArchives of General Psychiatry, 2008
- Corticolimbic Transcriptome Changes are State-Dependent and Region-Specific in a Rodent Model of Depression and of Antidepressant ReversalNeuropsychopharmacology, 2008
- Reduced Dendritic Spine Density in Auditory Cortex of Subjects with SchizophreniaNeuropsychopharmacology, 2008
- Alterations in Somatostatin mRNA Expression in the Dorsolateral Prefrontal Cortex of Subjects with Schizophrenia or Schizoaffective DisorderCerebral Cortex, 2008
- GAD67-Mediated GABA Synthesis and Signaling Regulate Inhibitory Synaptic Innervation in the Visual CortexNeuron, 2007
- Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophreniaMolecular Psychiatry, 2007
- Impairments in frontal cortical γ synchrony and cognitive control in schizophreniaProceedings of the National Academy of Sciences, 2006